Michele Malaguarnera

3.1k total citations
56 papers, 2.2k citations indexed

About

Michele Malaguarnera is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Michele Malaguarnera has authored 56 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 15 papers in Hepatology and 10 papers in Physiology. Recurrent topics in Michele Malaguarnera's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (10 papers) and Lipoproteins and Cardiovascular Health (6 papers). Michele Malaguarnera is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (10 papers) and Lipoproteins and Cardiovascular Health (6 papers). Michele Malaguarnera collaborates with scholars based in Italy, United States and Spain. Michele Malaguarnera's co-authors include Giulia Malaguarnera, Marco Vacante, Fabio Galvano, Giovanni Li Volti, Gaetano Bertino, Filippo Drago, Mariano Malaguarnera, Maria Giordano, Filippo Caraci and Annalisa Ardiri and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Chemosphere.

In The Last Decade

Michele Malaguarnera

55 papers receiving 2.2k citations

Peers

Countries citing papers authored by Michele Malaguarnera

Since Specialization

Citations

This map shows the geographic impact of Michele Malaguarnera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Malaguarnera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Malaguarnera more than expected).

Fields of papers citing papers by Michele Malaguarnera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Malaguarnera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Malaguarnera. The network helps show where Michele Malaguarnera may publish in the future.

Co-authorship network of co-authors of Michele Malaguarnera

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Malaguarnera. A scholar is included among the top collaborators of Michele Malaguarnera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Malaguarnera. Michele Malaguarnera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease 2025 ·Biomolecules ·Michele Malaguarnera, Omar Cauli, Andrea Cabrera‐Pastor	4
2	Trace elements in ALS patients and their relationships with clinical severity 2018 ·Chemosphere ·(unknown), Giuliana Solinas, Giovanni Forte, Beatrice Bocca, Cristiano Farace, (unknown), Maria Alessandra Sotgiu, (unknown), Michele Malaguarnera, Alessandro Giuseppe Fois, Pietro Pirina, Andrea Montella, Roberto Madeddu	19
3	Essential trace elements in amyotrophic lateral sclerosis (ALS): Results in a population of a risk area of Italy 2017 ·Neurological Sciences ·Giovanni Forte, Beatrice Bocca, (unknown), (unknown), Yolande Asara, Maria Alessandra Sotgiu, Cristiano Farace, Andrea Montella, Alessandro Giuseppe Fois, Michele Malaguarnera, Pietro Pirina, Roberto Madeddu	16
4	Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability 2016 ·BMC Psychiatry ·Giulia Malaguarnera, Gaetano Bertino, G Chisari, Massimo Motta, Michele Vecchio, Marco Vacante, Filippo Caraci, (unknown), Filippo Drago, G. Nunnari, Michele Malaguarnera	22
5	Influence of metals on rhinosinusal polyposis in Sardinian population (Italy) 2016 ·Environmental Science and Pollution Research ·Yolande Asara, Andrea Melis, (unknown), (unknown), Paolo Castiglia, Giannina Chessa, (unknown), Apostolos Karligkiotis, Pasquale Bandiera, Michele Malaguarnera, Juan Antonio Marchal, Roberto Madeddu	2
6	A New Sampling Method for Spleen Stiffness Measurement Based on Quantitative Acoustic Radiation Force Impulse Elastography for Noninvasive Assessment of Esophageal Varices in Newly Diagnosed HCV-Related Cirrhosis 2014 ·BioMed Research International ·Leonardo Rizzo, Massimo Attanasio, Marilia Rita Pinzone, Massimiliano Berretta, Michele Malaguarnera, Aldo Morra, Luca L’Abbate, Luca Balestreri, Giuseppe Nunnari, Bruno Cacopardo	25
7	Clinical Pharmacology of Novel Anti-Alzheimer Disease Modifying Medications 2013 ·Current Topics in Medicinal Chemistry ·Filippo Caraci, Paolo Bosco, Gian Marco Leggio, Michele Malaguarnera, Filippo Drago, Claudio Bucolo, Salvatore Salomone	9
8	Metal fume fever 2013 ·The Lancet ·Michele Malaguarnera, Filippo Drago, Giulia Malaguarnera, Giovanni Li Volti, Salvatore Salomone, Filippo Caraci, Fabio Galvano, Marco Vacante, Claudio Bucolo, Mariano Malaguarnera	5
9	Parkinson's disease: Therapeutic options 2012 ·(unknown), Ignazio Vecchio, Michele Malaguarnera, Giuseppe Battaglia, Liborio Rampello	1
10	Depression in older breast cancer survivors 2012 ·BMC Surgery ·(unknown), Marco Vacante, Michele Malaguarnera, (unknown), Francesca Catalano, Emanuela Cataudella, Filippo Drago, Giulia Malaguarnera, Francesco Basile, Antonio Biondi	26
11	Hepatocellualar Carcinoma Serum Markers 2012 ·Seminars in Oncology ·Gaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Nicoletta Bertino, (unknown)	135
12	Sclerosi laterale amiotrofica: Diagnosi differenziale con la mieloradicolopatia cervicale 2011 ·(unknown), Martino Ruggieri, Ignazio Vecchio, Giuseppe Battaglia, Clara Grazia Chisari, Michele Malaguarnera, (unknown), (unknown), Liborio Rampello	1
13	Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin 2011 ·Hepatitis Monthly ·Michele Malaguarnera, Marco Vacante, Cristina Russo, Maria Pia Gargante, (unknown), Gaetano Bertino, Sergio Neri, Mariano Malaguarnera, Fabio Galvano, Giovanni Li Volti	18
14	The Supplementation of Acetyl- l -Carnitine Decreases Fatigue and Increases Quality of Life in Patients with Hepatitis C Treated with Pegylated Interferon-α 2b Plus Ribavirin 2011 ·Journal of Interferon & Cytokine Research ·Michele Malaguarnera, (unknown), Marco Vacante, Gaetano Bertino, Sergio Neri, Mariano Malaguarnera, Maria Pia Gargante, Massimo Motta, Lorenzo Lupo, G Chisari, Cosimo Marcello Bruno, Giovanni Pennisi, Rita Bella	23
15	Neuroprotective effect of silibinin in diabetic mice 2011 ·Neuroscience Letters ·Giuseppina Marrazzo, Paolo Bosco, (unknown), Giovanni Scapagnini, C. Di Giacomo, Michele Malaguarnera, Fabio Galvano, (unknown), Giovanni Li Volti	70
16	Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: A randomized clinical trial 2010 ·Archives of Gerontology and Geriatrics ·Massimo Motta, Cristina Russo, Marco Vacante, (unknown), (unknown), Lisa Cammalleri, (unknown), (unknown), (unknown), Enrico Mondati, Michele Malaguarnera, Giovanni Pennisi	1
17	Revision of the ADA-classification of diabetes mellitus type 2 (DMT2): The importance of maturity onset diabetes (MOD), and senile diabetes (DS) 2010 ·Archives of Gerontology and Geriatrics ·Marco Vacante, Michele Malaguarnera, Massimo Motta	11
18	Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin 2009 ·Metabolism ·Mariano Malaguarnera, (unknown), Marco Vacante, Massimo Motta, Michele Malaguarnera, Giovanni Li Volti, Fabio Galvano	34
19	Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients 2009 ·Archives of Gerontology and Geriatrics ·Michele Malaguarnera, Marco Vacante, (unknown), Alessandro Cappellani, Erika Cristaldi, Massimo Motta	17
20	Progressive Supranuclear Palsy: Clinical, Pharmacological and Bioethical Implications 1969 ·Current Alzheimer Research ·Ignazio Vecchio, (unknown), Giulia Malaguarnera, Nicola Luigi Bragazzi, Michele Malaguarnera	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact